Mortality and potential years of life lost of lymphoma in Wuhan residents,2010—2019
10.3969/j.issn.1006-2483.2026.03.015
- VernacularTitle:2010—2019武汉市居民淋巴瘤死亡及减寿分析
- Author:
Xiaoxia ZHANG
1
;
Pulin LIU
1
;
Yuanyuan ZHAO
1
;
Qing DENG
1
;
Jinmeng XIONG
1
;
Juan DAI
1
Author Information
1. Chronic Disease Prevention and Control, Wuhan Center for Disease Control and Prevention, Wuhan, Hubei 430015, China
- Publication Type:Journal Article
- Keywords:
Lymphoma;
Mortality rate;
Potential years of life lost rate
- From:
Journal of Public Health and Preventive Medicine
2026;37(3):71-74
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the epidemiological characteristics of lymphoma mortality and potential years of life lost among Wuhan residents, and to provide a scientific basis for the prevention and control of lymphoma. Methods Data on lymphoma deaths among residents in Wuhan from 2010 to 2019 were collected from the population-based Wuhan Mortality Surveillance System. Joinpoint regression model was used to evaluate the trends in age-standardized mortality rates and potential years of life lost due to lymphoma among the residents of different ages and genders. Potential years of life lost rate was used to assess the disease burden. Results There were 4 055 deaths (2481in male and 1 574 in female) from major kidney diseases in Wuhan residents between 2010 to 2019, with an age-standardized mortality rate of 5.11/100 000. The mortality rate of major kidney diseases showed an upward trend with increasing age. Between 2010 and 2019, the age-standardized mortality rates of the multiple myeloma and non-Hodgkin lymphoma were significantly increased (APC=6.924%, APC=1.407%, P＜0.05), and the potential years of life lost rate of non-Hodgkin lymphoma in female were significantly increased (APC=7.935%，P＜0.05). Conclusion From 2010 to 2019, the mortality rate of lymphoma among residents of Wuhan City shows an upward trend, especially for multiple myeloma and non-Hodgkin lymphoma. The disease burden of multiple myeloma shows an increasing trend in the female population, suggesting the need to take corresponding preventive and control measures.
